UNMATCHED SUPPLY CHAIN SOLUTIONS FOR THE LIFE SCIENCES INDUSTRY

643
Active Clinical Trials
9
Commercial Products
600,000+
Shipments
150+
Countries
2022’s Data ManagementTransitionsWebinar

2022’s Data Management Transitions Webinar

Are your advanced therapy supply chains ready for this year’s 4G/LTE data management transition?

  • How will capacity and connectivity challenges impact carrier services and packaging technology providers?
  • How can you guarantee the certainty of global coverage and data fidelity for your cell and gene therapy shipments?
WATCH NOW
Download our ISO 21973 White Paper

Download our ISO 21973 White Paper

A leap forward in standardizing the regenerative medicine supply chain

  • Ensuring full compliance at every step in the transportation process
  • Standardization at scale
  • Mitigating risk in a zero failure environment
LEARN MORE

The Latest From Our Blog View All

Documentary: Cell & Gene Therapy - Advancing The Next Generation of Pharmaceuticals

In this video documentary, American Pharmaceutical Review and Pharmaceutical Outsourcing magazine spoke with Cryoport Systems' CEO, Mark Sawicki, VP Global BioServices, Rob Jones, and fellow industry experts to learn how cell and gene therapies are changing the healthcare landscape and what needs to be done to bring these advanced therapies to patients. Mark and Rob specifically share their expertise on supply chain and distribution in this documentary.  

Through Our Newly Launched Global Supply Chain Centers, Cryoport Systems Now Offers Kit Production

Cryoport combines its expertise in temperature-controlled supply chain solutions to develop a comprehensive offering of vein-to-vein services, one of which includes Kit Production. From clinical to commercial, our team works directly with your team to curate the specific kitting components for manufacturing, testing and clinical use. Developing a standardized and high-quality kitting solution requires the same level of attention as every other step in the collection, transportation and distribution process. In order to mitigate risk when focusing on kitting, it is imperative that all components are centrally managed and distributed. Cryoport has an experienced team that can work with you to develop a custom blood sample kit that fits your clinical or commercial needs. Implementing a centrally managed kitting solution helps to maximize the quality of your biological samples. It reduces inconsistencies in labels, vials, needles, tubes and other kit components, while also reducing unforeseen variables such as expiration dates and lot numbers for all global collections.  

Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC

Cryoport Systems has officially launched our BioServices solutions through our two new Global Supply Chain Centers. Learn More